Persistent pharmacokinetic challenges to pediatric drug development

The development of new therapeutic agents for the mitigation of pediatric disorders is largely hindered by the inability for investigators to assess pediatric pharmacokinetics (PK) in healthy patients due to substantial safety concerns. Pediatric patients are a clinical moving target for drug delive...

Descripción completa

Detalles Bibliográficos
Autores principales: Sage, Daniel P., Kulczar, Christopher, Roth, Wyatt, Liu, Wanqing, Knipp, Gregory T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145254/
https://www.ncbi.nlm.nih.gov/pubmed/25221567
http://dx.doi.org/10.3389/fgene.2014.00281

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145254/
https://www.ncbi.nlm.nih.gov/pubmed/25221567
http://dx.doi.org/10.3389/fgene.2014.00281

Ejemplares similares